This case report illustrates that prompt diagnosis and management of myositis, a rare manifestation of Systemic Lupus Erythematosus, can lead to favorable patient outcomes, as demonstrated by symptom resolution and normal electromyocardiography findings.
November 2025 in “British Journal of Dermatology” This guideline by the British Association of Dermatologists reviews managing alopecia areata and provides 56 recommendations but reports no new clinical results.
August 2025 in “International Journal of Scientific Research in Biological Sciences” In this study, women with polycystic ovarian syndrome were found to have significantly higher blood levels of DHEA, IL-6, and TNF-α compared to healthy controls.
April 2025 in “Medical Science” This review of existing clinical studies suggests that the ketogenic diet may help women with PCOS improve insulin sensitivity, reduce hyperandrogenism, and lose weight, although its long-term safety and hormonal impact require further investigation.
December 2024 in “Skin Appendage Disorders” Researchers reviewed 13 clinical trials on non-prescription monotherapies like procyanidin and cetirizine for androgenetic alopecia, finding potential improvements in hair density and diameter, but emphasized the need for more robust trials to confirm efficacy and safety.
July 2024 in “International Society of Hair Restoration Surgery” The abstract does not report any results or findings, instead it provides an overview of the Annual Conference of the British Association of Hair Restoration Surgery, which featured a variety of educational sessions chaired by Dr. Greg Williams.
January 2024 in “Journal of Ayurveda and integrative medicine” This paper discusses the potential of millets as a dietary intervention to help manage chemotherapy side effects in cancer patients, suggesting that their nutrient profile and various health benefits could support treatment without increasing medication burden.
January 2023 in “IP International Journal of Comprehensive and Advanced Pharmacology” This review discusses immunomodulatory formulations to address post-COVID conditions and reports no new clinical findings.
January 2023 in “International journal of homoeopathic sciences” This study collected data on PCOS symptoms among female students and assessed the prevalence of menstrual irregularities, obesity, hirsutism, alopecia, and severe acne in this group.
September 2022 in “Zenodo (CERN European Organization for Nuclear Research)” This article discusses Fluxactive Complete, a natural supplement for prostate health, and reports no new clinical results.
September 2022 in “Piretc” This review explores factors influencing export potential, including resource availability, technological innovation, and labor efficiency, but provides no new empirical results.
December 2017 in “Facial plastic surgery” In this review, the authors discuss how advanced hair transplantation techniques can improve the aesthetic outcome of facial trauma involving hair-bearing areas, emphasizing the role of adjuvant therapies like fat transfer and platelet-rich plasma to enhance hair regrowth.
January 1997 in “International Society of Hair Restoration Surgery” This segment on Dateline NBC investigated a US hair restoration clinic using hidden cameras, but the article reports no new research findings.
19 citations
,
July 2017 in “PLoS ONE” This study suggests that passage number significantly affects in silico scratch assay results, highlighting the importance of reporting passage number for reproducibility in cell culture experiments.
7 citations
,
July 2017 in “bioRxiv (Cold Spring Harbor Laboratory)” This study's in silico experiments suggest that the average cell proliferation rate can vary with passage number, highlighting the importance of reporting passage numbers for reproducibility in cell culture studies.
2 citations
,
January 2025 in “touchREVIEWS in Endocrinology” This study suggests that sodium-glucose cotransporter-2 inhibitors, alone or with metformin or GLP1RA, may improve metabolic and hormonal parameters in women with polycystic ovary syndrome.
This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.
This study developed expert consensus guidelines on using low-dose oral and topical minoxidil for pattern hair loss around hair transplant surgery, recommending specific doses, monitoring practices, and timing of use for both male and female patients.
This study developed consensus guidelines for using low-dose oral and topical minoxidil in patients undergoing hair transplant surgery for pattern hair loss, recommending dosing adjustments, monitoring protocols, and timing for post-surgery application.
February 2026 in “Expert Opinion on Pharmacotherapy” This study established consensus-based guidelines for using low-dose oral and topical minoxidil in managing pattern hair loss for patients undergoing hair transplant surgery, recommending specific dosages, monitoring procedures, and timing for initiation post-surgery.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This abstract provides an overview of androgenic alopecia diagnosis and management in general practice, highlighting reliance on clinical evaluation and the use of validated topical and oral treatments to halt disease progression and promote hair regrowth.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research abstract outlines that in general practice, androgenic alopecia is diagnosed through clinical evaluation, with management strategies focusing on stopping disease progression and promoting hair regrowth using validated topical and oral treatments.
January 2026 in “British Journal of Health Psychology” This review highlights the significant impact of alopecia on personal identity and social interactions, emphasizing the need for personalized, non-pharmacological interventions and improved collaboration in healthcare training to better support those with appearance-altering conditions.
January 2026 in “Spectrum Research Repository (Concordia University)” In this systematic meta-synthesis, the researchers observed substantial variation in how individuals with alopecia manage identity and appearance changes, highlighting difficulties with acceptance, social influences, and unmet treatment needs, thus emphasizing personalized support through non-pharmacological interventions.
November 2025 in “Frontiers in Endocrinology” This review examines the potential of apigenin and ellagic acid as adjunct or alternative treatments for PCOS, but reports no new clinical results and highlights the need for further trials to confirm their efficacy and optimize dosing and delivery.
October 2025 in “Journal of the Endocrine Society” This case study reported that a 40-year-old woman with Graves' disease developed severe thrombocytopenia after starting methimazole, suggesting a rare but serious risk of methimazole-induced immune thrombocytopenia and underscoring the need for close monitoring.
September 2025 in “Wound Repair and Regeneration” This review suggests that glucagon-like peptide 1 receptor agonists may play a potentially protective role in managing diabetic foot ulcers, particularly by addressing various underlying pathophysiological aspects.
May 2025 in “International Research Journal of Ayurveda & Yoga” This pilot study found that using a topical Carica papaya latex gel for 28 days reduced hair fall and promoted hair regrowth in individuals with Indralupta, although the bald patch size did not significantly change, indicating the potential need for longer treatment or additional interventions.
March 2025 in “Journal of Cutaneous and Aesthetic Surgery” In this study, three different hair serums were tested for their impact on Telogen effluvium in adult females, finding all effective in reducing hair shedding, with the cytokine-based serum showing the most significant improvement, reducing hair fall by 54.6% without adverse effects.
September 2022 in “Journal of the American Academy of Dermatology” In this study, targeted vitamin and mineral supplementation in alopecic patients with laboratory abnormalities did not significantly improve hair density or caliber.